Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of perampanel in post-stroke epilepsy
ChiCTR2400079424Phase 4Not yet recruiting
- Sponsor
- Shandong First Medical University
- Start
- Jan 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perampanel in epilepsy, sponsored by Shandong First Medical University. Primary endpoint: Responder rate at 12 months. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2400079424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079424.